Researchers in Beijing built logistic regression and XGBoost models that predict bone scintigraphy diagnostic categories before scanning, finding that probability calibration restores reliability ...

Breast cancer survivor Sue Weldon discusses survivorship gaps, integrative therapies alongside treatment and why caregivers ...

OS Therapies Inc. OSTX announced a statistically significant three-year overall survival benefit for patients treated with OST-HER2 in its Phase 2b trial. The study evaluated the prevention or delay ...

Broader community enrollment improves external validity by capturing patients with comorbidities and real-world treatment patterns, while familiarizing clinicians with toxicity management before ...

Late-breaking Phase 3 C-POST data provide longer-term survival outcomes for adjuvant Libtayo ® (cemiplimab) in high-risk cutaneous squamous cell ...

Pioneering South African researcher Dr Shiksha Gallow's study reveals that combining medicinal cannabis with chemotherapy led to a 63% rate of remission or tumor ...

A new study reveals that an AURKA-driven phosphorylation and SUMOylation cascade stabilizes the protein SPICE1, fueling ...

The U.S. Food and Drug Administration (FDA) has determined that a CBD- and THC-based drug being developed to control bone ...

Explore the NASA Crew-12 ISS science return and discover how experiments in microgravity enhance drug development.

BBC News presenter Maryam Moshiri has revealed she has been battling an incurable form of blood cancer while continuing to ...

Companies to Meet Formally with FDA’s Center for Veterinary Medicine on November 19th for Pre-Submission Conference; U.S. Manufacturing Strategy Underway to Support Potential 2027 Veterinary Product L ...

Androgen deprivation therapy (ADT) can be an effective treatment for men diagnosed with prostate cancer. By blocking testosterone, the therapy can slow or stop the cancer, contributing to a disease ...